Navigation Links
ViroPharma to Present at the Natixis Bleichroeder Conference
Date:10/3/2007

EXTON, Pa., Oct. 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the Natixis Bleichroeder Conference at 10:30 A.M. ET on Monday, October 8, 2007. The conference is being held at the Carlton Hotel in New York.

ViroPharma's presentation will be webcast live for investors through http://www.viropharma.com and available through October 22, 2007.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...rch report is available in its catalogue: ,, E...rspective ,, http://www.reportlinker.com/p016...ket-Perspective.html ,, Electrodes in electron...muscle and nerve cells that are created by chemica...
(Date:12/2/2009)..., , FRAZER, Pa., Dec. 2 /PRNewswire-Fi...announced that it has filed a lawsuit in U.S. Dist...s USA, Inc. for infringement of U.S. Patent Nos. 7... Patent") and RE37,516 (the ",516 Patent") for the...ets [C-IV]. Cephalon has a three-year period of m...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...rch report is available in its catalogue: ,, H..., http://www.reportlinker.com/p0164230/Hemoglo..., The seriousness of affliction and the need for...he emergence of a significant market for monitorin...
Breaking Medicine Technology:Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7NeoStem Featured on CBS2 News 3B Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems 3B Procedure to be Used by NeoSt 13044 1NeoStem Featured on CBS2 News 3B Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems 3B Procedure to be Used by NeoSt 13044 2NeoStem Featured on CBS2 News 3B Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems 3B Procedure to be Used by NeoSt 13044 3NeoStem Featured on CBS2 News 3B Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems 3B Procedure to be Used by NeoSt 13044 4Versus Technology Inc Partners With Microsoft 28R 29 To Promote Health Care Automation in Windows 7 Computing Environments 51774 1Versus Technology Inc Partners With Microsoft 28R 29 To Promote Health Care Automation in Windows 7 Computing Environments 51774 2Versus Technology Inc Partners With Microsoft 28R 29 To Promote Health Care Automation in Windows 7 Computing Environments 51774 3Schering Plough Expands Vicriviroc Phase II Study in Treatment Naive Patients With HIV 4727 1Schering Plough Expands Vicriviroc Phase II Study in Treatment Naive Patients With HIV 4727 2Schering Plough Expands Vicriviroc Phase II Study in Treatment Naive Patients With HIV 4727 3Schering Plough Expands Vicriviroc Phase II Study in Treatment Naive Patients With HIV 4727 4Schering Plough Expands Vicriviroc Phase II Study in Treatment Naive Patients With HIV 4727 5
...ewswire-FirstCall/ --,Phosphagenics Limited (AIM: ...nical studies of its TPM-02 dermal drug delivery,t... topical,treatment for severe acne and an active i...f of concept studies showed a three-fold increase ...skin when formulated,with TPM-02 compared to a con...
...USNewswire/ -- Childhood,cancers are fortunately r...se, accounting for 7 percent of all childhood canc... typically occurs as a,solid tumor in the abdomen,...ng in the network of the body,s sympathetic nervou...a heterogeneous disease;,its name includes subtype...
Other Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 2Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 3
(Date:12/2/2009)...ASADENA, Calif., Dec. 2 ... received the Gold Seal of Approval from the Joint...roke center. This means Huntington will join the ...ughout Los Angeles County. ,, "This is a sign...tant, a wonderful benefit for Pasadena and its sur...
(Date:12/2/2009)... , New Directors Represent Diverse Hea...PRNewswire-USNewswire/ -- The membership of the Na...s to its Board of Directors and reappointed four c...ent a wide range of healthcare stakeholders, inclu...s, and public and community healthcare. ,, The...
(Date:12/2/2009)... , Ruling by federal government ends nine mo...NGELES, Dec. 2 More tha...er Permanente facilities across Southern Californi...ational Union of Healthcare Workers (NUHW). ,, ...NUHW in February, but SEIU delayed the election by...
(Date:12/2/2009)...ancer patients who have a prostate-specific antige...years after external beam radiation therapy (EBRT)...ancer-related death, according to a study in the D...diation Oncology*Biology*Physics, the official jou...y (ASTRO)., PSA levels in a prostate cancer pati...
(Date:12/2/2009)... AB First Aid has been a top name in ...n 1980. With quality products, professional staff,...d supplies, AB First Aid has established itself as...ance care, and as a first aid supplies distributor...s is about to enter into its next phase with the r...
Breaking Medicine News(10 mins):Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3
...CETON, N.J., July 23 The New Jersey,Hospital Asso... has,received a planning grant for $199,502 from t...p a proposal for improving the quality of,healthca... initiative,which is focused on lifting the overal...
...ANG, China, July 23 /Xinhua-PRNewswire-FirstCall/ ...Bulletin Board: GTEC) ("Genesis" or,the "Company")... Republic,of China, held a Board of Directors meet...ation Committee were formed., Mr. Michael Marks w...
...PETERSBURG, Fla., July 23 Laura Kolkman, Presiden... information exchange,consulting firm, has been se...tion and Management Systems Society (HIMSS) Health... payers, vendors, consultants and life,sciences, l...
...AGO, July 23 A new survey of employers by the,non...nds the new Illinois,smoking cessation law, the Sm...employees overcome some barriers, but removing smo...ployer involvement in reducing tobacco,use among w...
...icking up on innuendo and social cues is a central... with autism often struggle to determine another p...search from Carnegie Mellon University sheds light...us. , According to the study, which is available...
... Online Clinicians Guide to ...Edison Pharma , Boston (P...day the completion of the Clinicians Symptom Guide... by mitochondrial disease. The Clinicians Symptom ...
Other Medicine News:Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2Health News:Stopping Smoking in the Workplace Continues to Be a Challenge 2Health News:Stopping Smoking in the Workplace Continues to Be a Challenge 3Health News:Autism's social struggles due to disrupted communication networks in brain 2Health News:MitoAction Develops On-Line Resource for Mitochondrial Disease Care Providers 2
CLEARBLUE EASY OVULATION TEST
Achieva CV
ResMed AutoSet Spirit
BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre Attached Holder
Medicine Products: